On Cancer

and/or

84 Blog posts found

Feature

The Treatments Changing Childhood Cancer: At Work with Filemon Dela Cruz

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

MSK pediatric oncologist Filemon Dela Cruz

In the Clinic

Taking on Mantle Cell Lymphoma: MSK Leads Research into New Treatments

Learn about novel therapies emerging for the treatment of mantle cell lymphoma.

MSK medical oncologist Anita Kumar

In the Clinic

How Acute Myeloid Leukemia Is Treated at MSK: An Interview with Martin Tallman

Learn about the latest advances in treatment for AML and how people can benefit from receiving their treatment at MSK.

Leukemia Service Chief Martin Tallman

Finding

Study Suggests More People with Kidney Cancer Should Be Screened for Hereditary Cancer Genes

Researchers have found that more than 20% of people with a type of cancer called advanced non-clear cell renal cell carcinoma have disease that is driven by inherited cancer mutations.

Papillary renal cell carcinoma under the microscope

Feature

Getting a Correct Diagnosis Is Vital for Treating Sarcoma, a Rare Cancer

MSK's experts in molecular pathology are finding new clues about these tumors.

MSK pathologist Cristina Antonescu in her laboratory

Announcement

FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia

The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.

Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello

In the Lab

Splicing May Be an Effective Target in the Fight against Cancer

New drugs are being developed that target part of the process to make proteins.

MSK physician-scientist Omar Abdel-Wahab

Finding

Findings from Two Patients Shed New Light on Drug Resistance in AML

A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.

Leukemia cells

Q & A

Meet Chronic Lymphocytic Leukemia Expert Anthony Mato

Meet hematologic oncologist Anthony Mato and learn why people who have been diagnosed with chronic lymphocytic leukemia should come to MSK.

Hematologic oncologist Anthony Mato

In the Lab

Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.

Blue cells containing small red and green dots on a black background